| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 48536* | 2017 |
| The international classification of headache disorders, (beta version) Headache Classification Committee of the International Headache Society (IHS) Cephalalgia 33 (9), 629-808, 2013 | 11449 | 2013 |
| Migraine prevalence, disease burden, and the need for preventive therapy RB Lipton, ME Bigal, M Diamond, F Freitag, ML Reed, WF Stewart Neurology 68 (5), 343-349, 2007 | 2767 | 2007 |
| Migraine and cardiovascular disease: systematic review and meta-analysis M Schürks, PM Rist, ME Bigal, JE Buring, RB Lipton, T Kurth Bmj 339, 2009 | 1003 | 2009 |
| Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population‐based study ME Bigal, D Serrano, D Buse, A Scher, WF Stewart, RB Lipton Headache: The Journal of Head and Face Pain 48 (8), 1157-1168, 2008 | 975 | 2008 |
| Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment ME Bigal, D Serrano, M Reed, RB Lipton Neurology 71 (8), 559-566, 2008 | 795* | 2008 |
| Fremanezumab for the preventive treatment of chronic migraine SD Silberstein, DW Dodick, ME Bigal, PP Yeung, PJ Goadsby, ... New England Journal of Medicine 377 (22), 2113-2122, 2017 | 773 | 2017 |
| Cutaneous allodynia in the migraine population RB Lipton, ME Bigal, S Ashina, R Burstein, S Silberstein, ML Reed, ... Annals of neurology 63 (2), 148-158, 2008 | 615 | 2008 |
| Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double‐blind, placebo‐controlled trial SD Silberstein, RB Lipton, DW Dodick, FG Freitag, N Ramadan, ... Headache: The Journal of Head and Face Pain 47 (2), 170-180, 2007 | 571 | 2007 |
| Migraine: epidemiology, impact, and risk factors for progression RB Lipton, ME Bigal Headache: The Journal of Head and Face Pain 45, S3-S13, 2005 | 569 | 2005 |
| Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study: CME S Diamond, ME Bigal, S Silberstein, E Loder, M Reed, RB Lipton Headache: The Journal of Head and Face Pain 47 (3), 355-363, 2007 | 553 | 2007 |
| Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial DW Dodick, SD Silberstein, ME Bigal, PP Yeung, PJ Goadsby, ... Jama 319 (19), 1999-2008, 2018 | 545 | 2018 |
| Obesity and migraine: a population study ME Bigal, JN Liberman, RB Lipton Neurology 66 (4), 545-550, 2006 | 502 | 2006 |
| The international classification of headache disorders, (beta version) DA Ettlin Cephalalgia 33 (9), 629-808, 2013 | 494 | 2013 |
| Modifiable risk factors for migraine progression ME Bigal, RB Lipton Headache: The Journal of Head and Face Pain 46 (9), 1334-1343, 2006 | 459 | 2006 |
| Migraine and cardiovascular disease: a population-based study ME Bigal, T Kurth, N Santanello, D Buse, W Golden, M Robbins, ... Neurology 74 (8), 628-635, 2010 | 449 | 2010 |
| Symptoms of temporomandibular disorders in the population: an epidemiological study. DA de Godoi Gonçalves, AL Dal Fabbro, JADB Campos, ME Bigal, ... Journal of orofacial pain 24 (3), 2010 | 431 | 2010 |
| Prevalence and characteristics of allodynia in headache sufferers: a population study ME Bigal, S Ashina, R Burstein, ML Reed, D Buse, D Serrano, RB Lipton Neurology 70 (17), 1525-1533, 2008 | 426 | 2008 |
| Obesity is a risk factor for transformed migraine but not chronic tension-type headache ME Bigal, RB Lipton Neurology 67 (2), 252-257, 2006 | 416 | 2006 |
| Chronic disorders with episodic manifestations: focus on epilepsy and migraine SR Haut, ME Bigal, RB Lipton The Lancet Neurology 5 (2), 148-157, 2006 | 399 | 2006 |
